Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,529.00
+203.00 (15.31%)
Jun 3, 2026, 3:30 PM JST
Renascience Market Cap
Renascience has a market cap or net worth of 18.27 billion as of June 2, 2026. Its market cap has increased by 43.86% in one year.
Market Cap
18.27B
Enterprise Value
14.87B
Revenue
68.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,529.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 18.27B, an increase of 80.26%. That is a compound annual growth rate of 13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 18.27B | -0.66% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuorips | 40.92B |
| Japan Tissue Engineering | 25.02B |
| AnGes | 19.42B |
| StemRIM | 18.55B |
| RaQualia Pharma | 13.04B |
| Stella Pharma | 12.51B |
| ReproCELL | 12.26B |
| CanBas | 11.68B |